Technology Coaching Intervention for Black Women With Hypertension

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

April 16, 2021

Study Completion Date

April 16, 2021

Conditions
Uncontrolled Hypertension
Interventions
BEHAVIORAL

Interactive Technology Enhanced Coaching (ITEC)

As participants wear the activity tracker, take their BP and weight, along with input of food intake and medication-taking, data is transmitted in real time via Bluetooth Smart technology to the Fitbit Plus dashboard. All data is tracked, analyzed, and transparently displayed for participants to view and better understand their condition, and actively engage in self-care. Staff monitor data and communicate with participants to encourage active engagement in action plans by sending tailored coaching messages (ITEC) via the Fitbit Plus dashboard to the treatment arm weekly for 3 months, and biweekly for 3 months to motivate and support (BP control, medication adherence, and lifestyle modifications). After 6 months, the treatment arm will be monitored an additional 3 months with no tailored coaching for sustainability.

BEHAVIORAL

Interactive Technology-No Coaching (IT)

After receiving usual care for 3 months, the control arm will receive the same electronic monitoring as the treatment arm and data will be captured in the same manner with the Fitbit Plus dashboard. Participants will be expected to use the information from the dashboard and the CDSMP workshop as a guide to self-care without coaching (IT). Staff will only monitor data. Control participants will not be contacted between repeated measures data collection periods, except to send reminders if they are not participating daily.

Trial Locations (1)

28223

Churches, Salons, Community Events, Charlotte

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of North Carolina, Charlotte

OTHER

NCT03577990 - Technology Coaching Intervention for Black Women With Hypertension | Biotech Hunter | Biotech Hunter